Skip to main content

Table 5 Effect of ANC characteristics of respondent on IPTp-SP uptake of ≥3 doses

From: Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana

Characteristics

IPTp-SP uptake

COR (95% CI)

p value

AOR (95% CI)

p value

<3 doses n (%)

≥3 doses n (%)

Gestational age at first ANC visit

 First trimester

7 (6.67)

98 (93.33)

Ref

 

Ref

 

 Second trimester

12 (9.52)

114 (90.48)

0.68 (0.26–1.79)

0.434

0.74 (0.22–2.46)

0.630

 Third trimester

13 (54.17)

11 (45.83)

0.06 (0.02–0.18)

<0.001

2.8 (0.31–24.55)

0.352

Number of visits

 <4

14 (48.28)

15 (51.72)

Ref

 

Ref

 

 ≥4

18 (7.96)

208 (92.04)

10.76 (4.5–25.82)

<0.001

4.57 (1.15–18.16)

0.031

Gestational age at first dose of SP

 Second trimester

11 (5.05)

207 (94.95)

Ref

 

Ref

 

 Third trimester

18 (52.94

16 (47.06)

0.05 (0.02–0.12)

<0.001

0.04 (0.01–0.16)

<0.001

  1. COR crude odds ratio, AOR adjusted odds ratio, 95% CI 95% confidence interval, Ref reference
  2. Significant p values are presented in italics